Clinton Bybee's Net Worth

$3.45 Million

Estimate Recalculated Apr 25, 2026 02:12PM EST

Who is Clinton Bybee

Clinton Bybee has an estimated net worth of $3.45 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., KYTHERA BIOPHARMACEUTICALS INC, PHASERX, INC., Neumora Therapeutics, Inc., Lyell Immunopharma, Inc., ADESTO TECHNOLOGIES Corp, AGIOS PHARMACEUTICALS INC, NeurogesX Inc, VBI VACCINES INC., Receptos, Inc., Gossamer Bio, Inc., Scholar Rock Holding Corp, Pulmatrix, Inc., Karuna Therapeutics, Inc., bluebird bio, Inc., Denali Therapeutics Inc., FATE THERAPEUTICS INC, Sage Therapeutics, Inc., Vir Biotechnology, Inc., Beam Therapeutics Inc., Metacrine, Inc., Bellerophon Therapeutics, Inc., Unity Biotechnology, Inc., Syros Pharmaceuticals, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., Juno Therapeutics, Inc., Homology Medicines, Inc., Achaogen Inc, Trubion Pharmaceuticals, Inc, CELEBRATE EXPRESS, INC., Boundless Bio, Inc., 908 Devices Inc., Quanterix Corp, Twist Bioscience Corp, XTERA COMMUNICATIONS, INC., ALNYLAM PHARMACEUTICALS INC, IMPINJ INC, XCYTE THERAPIES INC, and ILLUMINA INC.

SEC CIK

Clinton Bybee's CIK is 0001219043

Past Insider Trading and Trends

2019 was Clinton Bybee's most active year for acquiring shares with 6 total transactions. Clinton Bybee's most active month to acquire stocks was the month of May. 2018 was Clinton Bybee's most active year for disposing of shares, totalling 1 transactions. Clinton Bybee's most active month to dispose stocks was the month of May. 2017 saw Clinton Bybee paying a total of $97,720.00 for 6,440 shares, this is the most they've acquired in one year. In 2019 Clinton Bybee cashed out on 4,754 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sana Biotechnology, Inc.

Investor
Updated Feb 12, 2024
Feb 08
44.04MFeb 08
292.50K
Showing 3 results

KYTHERA BIOPHARMACEUTICALS INC

Investor
Updated Oct 16, 2012
Oct 16
Showing 2 results

PHASERX, INC.

Investor
Updated May 25, 2016
May 23
Form 3/A2.53M
2.49M
Showing 3 results

Neumora Therapeutics, Inc.

Investor
Updated Dec 12, 2023
31.93MDec 08
Sep 19
10.62M
Showing 3 results

Lyell Immunopharma, Inc.

Investor
Updated Jun 23, 2021
36.41MJun 21
Showing 2 results

ADESTO TECHNOLOGIES Corp

Investor
Updated Nov 03, 2015
2.28MOct 30
Oct 26
Showing 3 results

AGIOS PHARMACEUTICALS INC

Investor
Updated Feb 23, 2015
3.09MFeb 19
3.47MJun 23
3.86MJul 29
Showing 4 results

NeurogesX Inc

Investor
Updated Jul 25, 2011
Jul 21
Dec 24
2.53MMay 07
May 02
Showing 5 results

VBI VACCINES INC.

Investor
Updated Aug 17, 2015
Aug 13
Form 3/A3.40M
3.40M
Showing 3 results

Receptos, Inc.

Investor
Updated May 15, 2014
May 13 - May 14
May 14
114.29K
Showing 3 results

Gossamer Bio, Inc.

Investor
Updated Feb 12, 2019
8.06MFeb 12
Showing 2 results

Scholar Rock Holding Corp

Investor
Updated May 31, 2018
2.64MMay 29
Showing 2 results

Pulmatrix, Inc.

Investor
Updated Apr 12, 2018
5.74MApr 03
Form 4/A797.51KJun 15
Jun 15 - Jun 16
Showing 5 results

Karuna Therapeutics, Inc.

Investor
Updated Apr 15, 2021
2.92MApr 13
3.07MJan 08
3.21MNov 12
Jul 02
Showing 5 results

bluebird bio, Inc.

Investor
Updated Jun 26, 2013
1.79MJun 24
Showing 2 results

Denali Therapeutics Inc.

Investor
Updated Aug 12, 2019
10.67MAug 08
11.07MDec 12
312.50K
Showing 3 results

FATE THERAPEUTICS INC

Investor
Updated Oct 07, 2013
Oct 04
Showing 2 results

Sage Therapeutics, Inc.

Investor
Updated Jun 22, 2015
2.12MJun 18
3.19MJan 14
4.25MJul 23
Showing 4 results

Vir Biotechnology, Inc.

Investor
Updated Sep 07, 2022
27.09MSep 02 - Sep 06
28.98MAug 30 - Aug 31
30.91MAug 24 - Aug 25
16.18MAug 18
51.42MAug 12 - Aug 16
18.11MJun 08
18.59MJun 02
19.07MDec 20
20.76MNov 29
21.24MNov 22
21.73MJul 01
25.69MJun 22
53.86MApr 07 - Apr 08
55.85MMar 30 - Apr 01
Oct 16
444.44K
Showing 16 results

Beam Therapeutics Inc.

Investor
Updated Jul 02, 2021
5.89MJun 30
9.64MJun 25 - Jun 29
7.05MMar 31
11.37MMar 18 - Mar 22
8.24MFeb 10
Showing 6 results

Metacrine, Inc.

Investor
Updated Sep 22, 2020
Sep 18
Showing 2 results

Bellerophon Therapeutics, Inc.

Investor
Updated Feb 23, 2015
Feb 19
752.99K
Showing 2 results

Unity Biotechnology, Inc.

Investor
Updated May 07, 2018
10.05MMay 07
39.55K
Showing 2 results

Syros Pharmaceuticals, Inc.

Investor
Updated Jul 17, 2019
Jul 15 - Jul 17
Mar 12 - Mar 14
Mar 07 - Mar 11
Jul 06
213.33K
Showing 5 results

Codiak BioSciences, Inc.

Investor
Updated Sep 15, 2022
Sep 13
Oct 16
63.96K
Showing 3 results

Sienna Biopharmaceuticals, Inc.

Investor
Updated Feb 26, 2019
Feb 22
3.63MAug 01
Showing 3 results

Juno Therapeutics, Inc.

Investor
Updated Mar 17, 2016
10.55MMar 15
11.55MDec 23
1.10M
Showing 3 results

Homology Medicines, Inc.

Investor
Updated May 23, 2019
5.77MMay 21
6.07MApr 02
Showing 3 results

Achaogen Inc

Investor
Updated Mar 11, 2014
Showing 1 results

Trubion Pharmaceuticals, Inc

Investor
Updated Nov 01, 2010
Oct 28
2.36MOct 23
Oct 17
23.92K
Showing 4 results

CELEBRATE EXPRESS, INC.

Investor
Updated Sep 03, 2008
Aug 29
1.03MOct 25
89.85K
Showing 3 results

Boundless Bio, Inc.

Investor
Updated Apr 04, 2024
Apr 02
68.37K
Showing 2 results

908 Devices Inc.

Investor
Updated Dec 22, 2020
Dec 22
Showing 2 results

Quanterix Corp

Investor
Updated Nov 24, 2020
6.70MNov 20 - Nov 24
Dec 11
Showing 3 results

Twist Bioscience Corp

Investor
Updated Nov 06, 2018
Nov 02
Showing 2 results

XTERA COMMUNICATIONS, INC.

Investor
Updated Oct 13, 2016
500.17KOct 11
416.67KSep 27
166.67KSep 13
Nov 17
Nov 17
20.35K
20.35K
Showing 7 results

ALNYLAM PHARMACEUTICALS INC

Investor
Updated Jun 01, 2004
222.50K
Showing 1 results

IMPINJ INC

Investor
Updated Oct 23, 2020
17.13KOct 23
2.85KJun 10
13.71KNov 15
3.41KOct 23
423.78KAug 28
754.95KAug 13
750.19KJul 31
1.07MMay 03
1.38MJun 14 - Aug 13
Nov 09
2.02KJun 14
417.00Feb 21
Form 4/AJul 26
Jul 26
Showing 15 results

XCYTE THERAPIES INC

Investor
Updated Nov 02, 2004
851.06KOct 29
Mar 19
Form 3/A
Showing 4 results

ILLUMINA INC

Investor
Updated Feb 05, 2004
2.92MFeb 03
3.32MNov 26
Showing 2 results